Clinical Trials Logo

Clinical Trial Summary

To investigate the association of maternal serum concentrations of pentraxin 3 in early pregnancy with gestational diabetes mellitus and to explore its potential value in the prediction of GDM.


Clinical Trial Description

We recruited all pregnant women for the first checkup in our hospital . Maternal fasting serum PTX3 levels, fasting plasma glucose and fasting insulin and other factors were measured. Oral glucose tolerance test (OGTT) was performed at 24-28 weeks in all participants. According to the occurrence of GDM, subjects were divided into two groups: GDM group and normal glucose tolerance (NGT) group. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03563638
Study type Observational
Source Shanghai First Maternity and Infant Hospital
Contact
Status Completed
Phase
Start date October 1, 2015
Completion date December 1, 2015